Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „obinutuzumab“
Suchtreffer
Begriffe & Kennungen
Brukinsa · 4.8 · 34 Zanubrutinib in combination with obinutuzumab The most commonly occurring adverse reactions (≥20%) of zanub
Eintrag öffnenBrukinsa · 4.8 · 36 Table 4: Adverse reactions of zanubrutinib in combination with obinutuzumab reported in clinical study BGB-
Eintrag öffnenBrukinsa · 4.8 · 8 The most common Grade 3 or higher adverse reactions (>3%) of zanubrutinib in combination with obinutuzumab w
Eintrag öffnenBrukinsa · 4.8 · Adverse reactions in patients treated with BRUKINSA as monotherapy or in combination with obinutuzumab for B-c
Eintrag öffnenBrukinsa · 4.8 · Adverse reactions in patients treated with BRUKINSA as monotherapy or in combination with obinutuzumab for B-c
Eintrag öffnenBrukinsa · 4.8 · Of the 143 patients treated with BRUKINSA in combination with obinutuzumab, 42.0% were 65 years of age or olde
Eintrag öffnenBrukinsa · 4.8 · Of the 143 patients treated with BRUKINSA in combination with obinutuzumab, 42.0% were 65 years of age or olde
Eintrag öffnenBrukinsa · 4.8 · Of the 143 patients treated with zanubrutinib in combination with obinutuzumab, 4.9% of patients discontinued
Eintrag öffnenBrukinsa · 4.8 · Of the 143 patients treated with zanubrutinib in combination with obinutuzumab, 4.9% of patients discontinued
Eintrag öffnenBrukinsa · 4.8 · Table 4: Adverse reactions of zanubrutinib in combination with obinutuzumab reported in clinical study BGB-311
Eintrag öffnenBrukinsa · 4.8 · The most common Grade 3 or higher adverse reactions (>3%) of zanubrutinib in combination with obinutuzumab wer
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib in combination with obinutuzumab is based on ROSEWOOD study data from 143 p
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib in combination with obinutuzumab is based on ROSEWOOD study data from 143 p
Eintrag öffnenBrukinsa · 4.8 · Zanubrutinib in combination with obinutuzumab The most commonly occurring adverse reactions (≥20%) of zanubrut
Eintrag öffnenCalquence · 4.8 · 14 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnenCalquence · 4.8 · 15 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnenCalquence · 4.8 · 16 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnenCalquence · 4.8 · 17 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnenCalquence · 4.8 · 52 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnenCalquence · 4.8 · 54 Calquence + Calquence + Calquence + Calquence + BR venetoclax venetoclax + Obinutuzumab N=297 N=291 obinutu
Eintrag öffnen